Mucosal melanoma: clinicopathological, molecular and prognostic features in a retrospective cohort
Virchows Archiv · 08.04.2026
DOI: 10.1007/s00428-026-04490-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 08.04.2026. Verfasst von Antonio Carrasco Lorenzo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundació Institució dels Centres de Recerca de Catalunya.
Abstract (Originalsprache)
Mucosal melanoma represents a rare, aggressive malignancy with limited therapeutic options and sparse data on prognostic markers. Here, we assess histopathologic and molecular parameters influencing survival to identify features applicable in routine diagnostics. A retrospective single-centre clinicopathological study of 51 patients diagnosed with mucosal melanoma (genitourinary, head and neck and gastrointestinal) between 2016 and 2024 was performed. Histopathological parameters, including tumour-infiltrating lymphocytes, were assessed by pathologists with expertise on melanocytic lesions. Molecular data derived from previously performed next-generation sequencing panels targeting common oncogenic drivers were retrieved from pathology records. Molecular and histopathological findings were correlated with clinical data and survival outcomes. The findings highlight the prognostic relevance of proliferative activity and residual in situ disease. Disease-free survival was significantly reduced in patients with metastatic (M1) status, ulceration, ≥10 mitoses/mm 2 and amelanotic tumours on univariate analysis, although none of these variables remained significant in multivariate models. Overall survival (OS) was significantly lower in cases with M1 status and in the presence of an in situ component in both univariate and multivariate analyses; high mitotic activity showed a nonsignificant trend towards reduced OS in multivariate analysis. NRAS was the most frequent mutation, followed by ARID1A , CDK4 , CDKN2A , JAK2 and MYC , without a significant association with survival. These results emphasise the prognostic value of mitotic index and surgical completeness, while confirming the marked molecular heterogeneity of mucosal melanoma and the lack of a single dominant actionable alteration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
- University of Barcelona (UB), 08036, Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036, Barcelona, Spain.
- Molecular Biology Core Facility, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
- Department of Dermatology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
- Department of Pathology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain. lalos@clinic.cat.
Förderung
- Fundació Institució dels Centres de Recerca de Catalunya
Zitieren
APA
Carrasco Lorenzo, A., Lop Gros, J., Castrejón, N., García-Herrera, A., Albero-González, R., Saco, A., Montironi, C., Alonso, P., Luzon, I., López, V., Rodríguez, L., Carrera, C., Alòs, L., & Teixido, C. (2026). Mucosal melanoma: clinicopathological, molecular and prognostic features in a retrospective cohort. Virchows Archiv. https://doi.org/10.1007/s00428-026-04490-6
Vancouver
Carrasco Lorenzo A, Lop Gros J, Castrejón N, García-Herrera A, Albero-González R, Saco A, et al. Mucosal melanoma: clinicopathological, molecular and prognostic features in a retrospective cohort. Virchows Archiv. 2026. doi:10.1007/s00428-026-04490-6
BibTeX
@article{CarrascoLorenzo2026,
author = {Carrasco Lorenzo, Antonio and Lop Gros, Joan and Castrejón, Natalia and García-Herrera, Adriana and Albero-González, Raquel and Saco, Adela and Montironi, Carla and Alonso, Paula and Luzon, Irea and López, Vanessa and Rodríguez, Laura and Carrera, Cristina and Alòs, Llúcia and Teixido, Cristina},
title = {Mucosal melanoma: clinicopathological, molecular and prognostic features in a retrospective cohort},
journal = {Virchows Archiv},
year = {2026},
doi = {10.1007/s00428-026-04490-6}
}
EUVIMED